Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Capital Employed (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Return on Capital Employed data on record, last reported at 0.38% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 17.0% year-over-year to 0.38%; the TTM value through Sep 2025 reached 0.38%, up 17.0%, while the annual FY2024 figure was 0.92%, 1.0% up from the prior year.
  • Return on Capital Employed reached 0.38% in Q3 2025 per ABEO's latest filing, up from 0.54% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.38% in Q3 2025 and bottomed at 2.9% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 1.03%, with a median of 0.85% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: tumbled -225bps in 2022, then surged 199bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 1.09% in 2021, then decreased by -7bps to 1.16% in 2022, then increased by 22bps to 0.91% in 2023, then rose by 28bps to 0.65% in 2024, then soared by 41bps to 0.38% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.38% in Q3 2025, 0.54% in Q2 2025, and 0.81% in Q1 2025.